Stereotactic Body Radiotherapy

Stereotactic body radiotherapy, often abbreviated SBRT or sometimes SABR, is a highly focused form of external-beam radiotherapy that delivers very precise, high-dose treatment to a defined target over a small number of sessions. It is used in selected tumors where precision matters and where surrounding healthy tissues can be protected with careful planning. ^[1][2][3]

How does SBRT differ from conventional radiotherapy?

The key distinction is dose intensity and precision. Conventional external radiotherapy is often delivered over many fractions, whereas SBRT typically uses fewer treatment sessions with high doses per fraction. Because of this, immobilization, image guidance, motion management, and treatment planning become especially important. The goal is not simply “stronger radiation,” but highly accurate radiation delivered to the right target with tight margins. ^[1][2][4]

SBRT is often discussed for early-stage lung tumors in medically inoperable patients, selected liver lesions, some adrenal lesions, oligometastatic disease, spinal tumors, and other carefully chosen scenarios. However, not every tumor, body location, or patient is suitable. Tumor size, motion with breathing, proximity to critical organs, and prior radiation history all influence eligibility. ^[2][3][5]

In which situations may SBRT be considered?

SBRT may be considered when a localized lesion can be targeted precisely and when a short, high-precision course offers a favorable balance of effectiveness and convenience. In some settings it may be an alternative for patients who are not good surgical candidates; in others it may be used for local control in limited metastatic disease. The decision is always tumor-specific and should not be generalized across cancer types. ^[1][2][5]

A multidisciplinary discussion is often valuable because surgery, conventional radiotherapy, systemic therapy, ablation, and observation may all be reasonable alternatives depending on the case. Patient selection is therefore one of the main determinants of success. ^[2][4][6]

What are treatment planning and delivery like?

Before SBRT, the team usually performs simulation imaging and creates an individualized treatment plan. Depending on the tumor site, motion management techniques, custom immobilization devices, contrast-enhanced imaging, or respiratory tracking may be used. The patient may notice that planning seems more elaborate than expected, but that precision is exactly what makes SBRT possible. ^[1][3][4]

Treatment itself is noninvasive. The patient lies in the treatment position while the machine delivers radiation from planned angles. Sessions are usually painless, though staying still may be tiring for some people. Because side effects can vary by body region, the discussion before treatment should focus not only on the general concept of radiation but also on the exact location being treated. ^[1][2][5]

What side effects are possible?

Potential side effects depend heavily on the treatment site. Fatigue, local discomfort, skin effects, inflammation in nearby organs, or delayed tissue injury can occur. For example, lung SBRT may carry a risk of radiation pneumonitis, while abdominal or spinal targets raise different concerns. This is why broad statements such as “SBRT has no side effects” are misleading, even though many patients tolerate it well. ^[2][3][5]

The short treatment schedule should not be confused with a lack of seriousness. High precision reduces unnecessary exposure, but high dose per fraction also means planning errors or poor patient selection could matter greatly. That is why experienced centers and careful review are important. ^[1][4][6]

Why is tumor board review often necessary in patient selection?

Because the treatment decision often involves more than one acceptable option. A tumor board or multidisciplinary review helps weigh imaging findings, pathology, staging, prior treatments, surgical operability, systemic therapy options, and expected quality of life. This is particularly important in oligometastatic disease or borderline cases where the best strategy is not obvious from tumor location alone. ^[2][4][6]

How is follow-up performed after SBRT?

Follow-up usually includes symptom review and interval imaging. Radiologic changes after SBRT may evolve gradually, and early post-treatment scans do not always distinguish cleanly between expected treatment effect and persistent disease. For that reason, interpretation requires patience and clinical context. ^[1][2][5]

Patients should also be told which warning signs deserve attention, such as worsening shortness of breath, fever, severe pain, new neurologic symptoms, or significant functional decline, depending on the treated site. Follow-up is not just about confirming tumor response; it is also about identifying delayed toxicity early. ^[2][3][5]